PMC:7161517 / 963-1195 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T3","span":{"begin":49,"end":73},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T10","span":{"begin":88,"end":96},"obj":"Disease"},{"id":"T11","span":{"begin":205,"end":213},"obj":"Disease"}],"attributes":[{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":214,"end":217},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":55,"end":66},"obj":"Chemical"},{"id":"T14","span":{"begin":74,"end":84},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":169,"end":189},"obj":"Sentence"},{"id":"T9","span":{"begin":191,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T29","span":{"begin":49,"end":54},"obj":"PR:000013883"},{"id":"T30","span":{"begin":74,"end":84},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T31","span":{"begin":88,"end":98},"obj":"SP_7"},{"id":"T32","span":{"begin":205,"end":213},"obj":"SP_7"},{"id":"T79821","span":{"begin":49,"end":54},"obj":"PR:000013883"},{"id":"T54661","span":{"begin":74,"end":84},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T15931","span":{"begin":88,"end":98},"obj":"SP_7"},{"id":"T15393","span":{"begin":205,"end":213},"obj":"SP_7"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}

{"project":"LitCovid-PubTator","denotations":[{"id":"35","span":{"begin":88,"end":98},"obj":"Species"},{"id":"46","span":{"begin":205,"end":213},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:2697049"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hypothesized that the benefits of treatment with renin-angiotensin system inhibitors in SARS-CoV-2 may outweigh the risks and at the very least should not be withheld.\n\nCentral Illustration\n\nHighlights\n• COVID-19 has been associate"}